Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Novelion Therapeutics Inc (NVLNF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Novelion Therapeutics historical data, for real-time data please try another search
0.702 0.000    0.00%
04/02 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.700 - 0.750
Novelion Therapeutics 0.702 0.000 0.00%

NVLNF User Rankings

 
Bellow, users are ranked according to the performance of their sentiments for the Novelion Therapeutics Inc share.
RankUsernameTotalClosedWinningWin %Chg. %
1JF ISSENMANN333100+1550.71%
2Hussain Eid111100+982.16%
3Robbert Kuipers66466.67+858.22%
4Mahmood Mattar111100+812.87%
5JUAN VIÑUALES GARRIDO33133.33+766.42%
6Kamil Nowak111100+724.69%
7yai banlao111100+723.95%
8Matt Bowman111100+615.28%
9נועם גרינברג111100+614.73%
10Alberto Teruel111100+588.06%
11Lourdes Pereira111100+582.96%
12Juan Maldonado111100+572.99%
13Gal Marom111100+568.12%
14Angel Fernandez111100+540.28%
15Mathieu Chartrand111100+537.62%
16Michael Chénier111100+524.66%
17Wooka Grant111100+494.46%
18Skylar Wilhoite111100+458.79%
19Aaron Dominic111100+441.08%
20Muhammad Firdous111100+426.86%
21Connie Misch111100+417.98%
22Ezzat Mahran111100+412.22%
23Jabez Yeo111100+403.83%
24Emil Tsad111100+403.83%
25Ahmed Bawareth111100+403.28%
26Meir Avigezer111100+395.7%
27Nicholas Maney111100+393.05%
28Hussein Hanif111100+387.83%
29Matteo Giovagnoni111100+381.97%
30Mark Shivo111100+380.21%
31111100+368.02%
32Domingo Guerra Rodriguez111100+351.96%
33Armando cuko111100+342.42%
34Rogelio Jaralba111100+328.84%
35Zander Franco111100+328.84%
36John Pires111100+322.94%
37James Miller111100+317.19%
38Marcin Skawiniak111100+317.19%
39Christopher Muñoz111100+307.96%
40Hermann Albrecht333100+88.16%
41Ivica Maurovic111100+45.99%
42Minix Option111100+45.51%
43Jacopo Della Mea111100+21.98%
44Vladimir Yevtushenko111100+20.37%
45Saurabh Pawar222100+17.57%
46Laszlo Varga111100+17.41%
47Harley Maszczak111100+12.41%
48Илья Сторожев111100+11.81%
49Alex Nobili111100+10.94%
50naga raju111100+8.16%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVLNF Comments

Write your thoughts about Novelion Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email